Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-09-14 Sale | 2021-09-16 6:19 pm | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 1,388 | $25.04 | $34,760 | 228,772 (Indirect Direct) | View |
2021-09-10 Sale | 2021-09-14 4:03 pm | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 1,080 | $25.05 | $27,056 | 230,160 (Indirect Direct) | View |
2021-09-07 Sale | 2021-09-09 4:36 pm | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 1,086 | $25.11 | $27,272 | 231,240 (Indirect Direct) | View |
2021-06-01 Sale | 2021-06-02 4:11 pm | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 3,900 | $32.55 | $126,935 | 43,704 (Indirect Direct) | View |
2021-05-20 Sale | 2021-05-24 7:30 pm | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 1,400 | $25.15 | $35,208 | 232,326 (Indirect Direct) | View |
2021-05-14 Sale | 2021-05-18 8:22 pm | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 5,874 | $25.29 | $148,582 | 233,726 (Indirect Direct) | View |
2021-05-11 Sale | 2021-05-13 8:00 pm | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 100 | $25.11 | $2,511 | 239,600 (Indirect Direct) | View |
2021-04-28 Sale | 2021-04-30 7:59 pm | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 200 | $25.17 | $5,034 | 239,700 (Indirect Direct) | View |
2021-04-01 Sale | 2021-04-05 7:42 pm | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 100 | $25 | $2,500 | 239,900 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2023-09-14 7:26 pm | N/A N/A | RayzeBio Inc. | RYZB | Heyman Richard A. Director | 0 | $0 | 367,446 (Direct) | View |
2023-06-14 Option Award | 2023-06-15 4:54 pm | N/A 2033-06-13 | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 20,500 | $0 | 20,500 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 5:39 pm | N/A 2033-06-07 | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 21,500 | $0 | 21,500 (Direct) | View |
2023-02-23 Option Award | 2023-04-06 8:19 pm | N/A 2033-02-23 | Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director | 34,458 | $0 | 34,458 (Direct) | View |
2023-02-23 Option Award | 2023-02-27 9:54 pm | N/A 2032-08-12 | Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director | 239,056 | $0 | 201,649 (Direct) | View |
2022-05-18 Option Award | 2022-09-06 7:23 pm | N/A 2032-05-17 | Metacrine Inc. | MTCR | Heyman Richard A. Director | 16,500 | $0 | 16,500 (Direct) | View |
2022-06-17 Option Award | 2022-06-22 5:32 pm | N/A 2032-06-16 | Gritstone bio Inc. | GRTS | Heyman Richard A. Director | 19,000 | $0 | 19,000 (Direct) | View |
2022-06-17 Option Award | 2022-06-17 8:22 pm | N/A 2032-06-16 | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 53,700 | $0 | 53,700 (Direct) | View |
2022-06-02 Option Award | 2022-06-06 5:41 pm | N/A 2032-06-01 | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 19,500 | $0 | 19,500 (Direct) | View |
2021-06-18 Option Award | 2021-11-19 4:57 pm | N/A 2031-06-17 | Gritstone bio Inc. | GRTS | Heyman Richard A. Director | 19,000 | $0 | 19,000 (Direct) | View |
2021-05-12 Option Award | 2021-07-23 4:07 pm | N/A 2031-05-11 | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 5,781 | $0 | 5,781 (Direct) | View |
2021-06-16 Option Award | 2021-06-17 7:46 pm | N/A 2031-06-15 | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 16,625 | $0 | 16,625 (Direct) | View |
2021-06-02 Option Award | 2021-06-09 5:30 pm | N/A 2031-06-01 | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 16,333 | $0 | 16,333 (Direct) | View |
2021-06-02 Option Award | 2021-06-04 4:05 pm | N/A 2031-06-01 | YUMANITY THERAPEUTICS INC. | YMTX | Heyman Richard A. Director | 14,800 | $0 | 14,800 (Direct) | View |
2021-06-01 Exercise | 2021-06-02 4:11 pm | N/A N/A | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 2,925 | $2.95 | 43,704 (Indirect) | View |
2021-06-01 Exercise | 2021-06-02 4:11 pm | N/A 2027-08-16 | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 3,900 | $0 | 43,704 (Indirect) | View |
2021-06-01 Exercise | 2021-06-02 4:11 pm | N/A N/A | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 975 | $975 | 43,704 (Indirect) | View |
2021-05-24 Option Award | 2021-05-25 7:01 pm | N/A 2031-05-23 | Metacrine Inc. | MTCR | Heyman Richard A. Director | 16,500 | $0 | 16,500 (Direct) | View |
2021-02-01 Option Award | 2021-02-03 6:38 pm | N/A N/A | YUMANITY THERAPEUTICS INC. | YMTX | Heyman Richard A. Director | 1,959 | $0 | 8,117 (Direct) | View |
2020-12-22 Option Award | 2020-12-28 7:10 pm | N/A 2030-04-06 | YUMANITY THERAPEUTICS INC. | YMTX | Heyman Richard A. Director | 11,429 | $0 | 11,429 (Direct) | View |
2020-11-11 Option Award | 2020-11-12 4:14 pm | N/A 2030-06-22 | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 45,332 | $0 | 45,332 (Direct) | View |
Ownership | 2020-09-24 7:12 pm | N/A 2027-08-16 | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 0 | $0 | 244,044 (Direct) | View |
Ownership | 2020-09-16 12:06 pm | N/A N/A | Metacrine Inc. | MTCR | Heyman Richard A. Director | 0 | $0 | 189,019 (Direct) | View |
Ownership | 2020-09-03 06:19 am | N/A N/A | BCTG Acquisition Corp. | BCTG | Heyman Richard A. Director | 0 | $0 | 40,600 (Direct) | View |
2020-06-18 Option Award | 2020-06-22 5:30 pm | N/A 2030-06-18 | Gritstone Oncology Inc. | GRTS | Heyman Richard A. Director | 12,500 | $0 | 12,500 (Direct) | View |
2020-04-28 Conversion | 2020-04-28 5:08 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 62,500 | $0 | 240,000 (Indirect) | View |
2020-04-23 Option Award | 2020-04-27 4:39 pm | N/A 2030-04-22 | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 16,625 | $0 | 16,625 (Direct) | View |
Ownership | 2020-04-23 8:19 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 0 | $0 | 305,053 (Direct) | View |
2019-06-19 Option Award | 2019-06-20 4:10 pm | N/A 2029-06-19 | Gritstone Oncology Inc. | GRTS | Heyman Richard A. Director | 8,570 | $0 | 8,570 (Direct) | View |